(Q39461139)

12 September 2017

1 reference

title

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness (English)

1 reference

12 September 2017

P Benfield

1

1 reference

12 September 2017

R C Heel

series ordinal

2

1 reference

12 September 2017

S P Lewis

series ordinal

3

1 reference

12 September 2017

1 December 1986

1 reference

12 September 2017

1 reference

12 September 2017

32

1 reference

12 September 2017

481-508

1 reference

12 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198632060-00002

12 September 2017

0 references

cites work

Effect of biogenic amines reuptake inhibition on ethanol induced hypothermia

1 reference

12 December 2020

Effect of fluoxetine on the electrocardiogram.

1 reference

12 December 2020

The effect of a serotonin uptake inhibitor (Lilly 110140) on the secretion of prolactin in the rat

1 reference

12 December 2020

Effects of serotonin uptake inhibitor, Lilly 110140, on transport of serotonin in rat and human blood platelets

1 reference

12 December 2020

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder

1 reference

12 December 2020

Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance

1 reference

12 December 2020

Activity of desipramine, fluoxetine and nomifensine on spontaneous and P-CPA-induced muricidal aggression

1 reference

12 December 2020

Effect of an uptake inhibitor on serotonin metabolism in rat brain: Studies with 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine (Lilly 110140)

1 reference

12 December 2020

Role of 5-hydroxytryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice

1 reference

12 December 2020

Role of serotoninergic neurones in the control of gonadotrophin and prolactin secretion in the rat

1 reference

12 December 2020

Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats

1 reference

12 December 2020

Action of serotoninmimetics in the behavioral despair test in rats

1 reference

12 December 2020

Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors

1 reference

12 December 2020

Effect of blockade of 5-hydroxytryptamine re-uptake on drug-induced antinociception in the rat

1 reference

12 December 2020

Chlordiazepoxide-fluoxetine interactions on food intake in free-feeding rats

1 reference

12 December 2020

The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats

1 reference

12 December 2020

Effects of 5-hydroxytryptamine, fluoxetine and chlorimipramine on reflex bradycardia in rats

1 reference

12 December 2020

An investigation of the mechanisms of action of 5-hydroxytryptamine in the suppression of ethanol intake.

1 reference

12 December 2020

Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake

1 reference

12 December 2020

Intracranial reward after Lilly 110140 (fluoxetine HCl): Evidence for an inhibitory role for serotonin

1 reference

12 December 2020

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder

1 reference

12 December 2020

Effect of two non tricyclic antidepressant drugs on [14C]5-hydroxytryptamine uptake by rat platelets

1 reference

12 December 2020

Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses

1 reference

12 December 2020

Fluoxetine in the treatment of obsessive compulsive disorder

1 reference

12 December 2020

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine

1 reference

12 December 2020

Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine

1 reference

12 December 2020

The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue.

1 reference

12 December 2020

Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness

1 reference

12 December 2020

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder

1 reference

12 December 2020

Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors

1 reference

12 December 2020

Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin—comparison of fluoxetine and chlorimipramine

1 reference

12 December 2020

Characteristics of responders to fluoxetine

1 reference

12 December 2020

Drug-induced changes of brain serotoninergic tone and insulin-induced growth hormone release in the dog

1 reference

12 December 2020

Further Evidence That Serotonin Is a Neurotransmitter Involved in the Control of Prolactin Secretion

1 reference

12 December 2020

Fenfluramine-induced hyperthermia and stimulation in the rabbit

1 reference

12 December 2020

Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake.

1 reference

12 December 2020

Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant

1 reference

12 December 2020

Effects of increasing serotonergic receptor activity in brain on analgesic activity in rats

1 reference

12 December 2020

The effect of fluoxetine on warfarin metabolism in the rat and man

1 reference

12 December 2020

Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice.

1 reference

12 December 2020

Fluoxetine kinetics and protein binding in normal and impaired renal function

1 reference

12 December 2020

Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity

1 reference

12 December 2020

The effect of clomipramine and other amine-uptake inhibitors on morphine analgesia in laboratory animals

1 reference

12 December 2020

Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors

1 reference

12 December 2020

A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine

1 reference

12 December 2020

Effects of chronic fluoxetine administration on serotonin metabolism

1 reference

12 December 2020

Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake

1 reference

12 December 2020

Fluoxetine, a selective serotonin uptake inhibitor

1 reference

12 December 2020

Elevation of serum prolactin levels after the inhibition of serotonin uptake

1 reference

12 December 2020

A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder

1 reference

12 December 2020

Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol

1 reference

12 December 2020

Differential effects of antidepressant treatment on brain monoaminergic receptors

1 reference

12 December 2020

Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat

1 reference

12 December 2020

Fluoxetine in depressed patients: a comparison with imipramine

1 reference

12 December 2020

Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: Effects of Nisoxetine versus fluoxetine

1 reference

12 December 2020

Fluoxetine treatment of obsessive-compulsive disorder

1 reference

12 December 2020

Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats

1 reference

12 December 2020

Effect of fluoxetine, a serotonin reuptake inhibitor, on the pituitary-thyroid axis in rat.

1 reference

12 December 2020

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder

1 reference

12 December 2020

Mode of action of antidepressant drugs

1 reference

12 December 2020

Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding

1 reference

12 December 2020

Potentiation of morphine hyperthermia in cats by pimozide and fluoxetine hydrochloride

1 reference

12 December 2020

Pressor responses to tyramine and norepinephrine after subchronic administration of fluoxetine to man

1 reference

12 December 2020

Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors

1 reference

12 December 2020

The effects of fenfluramine and fluoxetine on the acquisition of the conditioned avoidance response in rats.

1 reference

12 December 2020

Evidence that Serotonin Stimulates a Prolactin-Releasing Factor in the Rat

1 reference

12 December 2020

Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake

1 reference

12 December 2020

Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in rats

1 reference

12 December 2020

Attenuation of pethidine-induced antinociception by zimelidine, an inhibitor of 5-hydroxytryptamine reuptake

1 reference

12 December 2020

Effects of Lilly 110140 (flouxetine) on self-stimulation behavior in the dorsal and ventral regions of the lateral hypothalamus in the mouse

1 reference

12 December 2020

Differences among 'serotonergic' anorectics in a cross-tolerance paradigm: do they all act on serotonin systems?

1 reference

12 December 2020

Comparison of two dosage regimens of fluoxetine in major depression

1 reference

12 December 2020

Adverse reactions in connection with zimeldine treatment - a review

1 reference

12 December 2020

Fixed-dose fluoxetine therapy for depression

1 reference

12 December 2020

The side effect profile and safety of fluoxetine

1 reference

12 December 2020

Enhancement of Insulin-Induced Prolactin Secretion by Fluoxetine in Man

1 reference

12 December 2020

Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats

1 reference

12 December 2020

Serotoninergic involvement in the effect of ethanol on body temperature in rats

1 reference

12 December 2020

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine

1 reference

12 December 2020

Inhibition of drug metabolism by fluoxetine

1 reference

12 December 2020

10.2165/00003495-198632060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

0 references

1 reference